Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Numidargistat + Chemotherapy in Advanced Solid Tumors
NCT03314935Phase 2Completed
- Sponsor
- Incyte
- Start
- Nov 2017
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of numidargistat in biliary tract cancer (BTC), colorectal cancer (CRC), endometrial cancer (EC), gastroesophageal junction cancer, ovarian cancer, sponsored by Incyte. Started Nov 2017; status: completed.
02
Drugs
numidargistat
03
Conditions
biliary tract cancer (BTC)colorectal cancer (CRC)endometrial cancer (EC)gastroesophageal junction cancerovarian cancer
Beyond the preview
Go deeper on NCT03314935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03314935.